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Summary.-Male Wistar rats fed a normal laboratory pelleted diet, when treated s.c.
with 1,2-dimethylhydrazine (DMH) 10 mg/kg/wk survived the 24-week experiment,
showed no signs of chemical toxicity or macroscopic liver damage, and developed
mainly large-bowel tumours. Conversely, male Wistar rats treated with20 mg/kg/wk
DMH did not survive the full term of the experiment and developed ascites, pleural
effusions and nodular livers. They also developed more small-bowel tumours than
large-bowel tumours. The relationship between the predominant site of tumour
development and dosage of DMH was highly significant.
Male Wistar rats fed with an all-liquid diet (Vivonex) and treated with20 mg/kg/wk
DMH behaved quite differently both in terms of survival and site of tumour develop-
ment. These rats survived the full term of the experiment, showed no signs of
chemical toxicity, experienced minimal liver damage and developed predominantly
large-bowel tumours. The protection afforded by the all-liquid diet against DMH
toxicity and small-bowel tumour induction was statistically highly significant.
A series of blood tests with special reference to liver function confirmed the highly
significant degree of protection against liver damage afforded by the all-liquid diet.
Sections of liver from treated rats were examined, and a simple pathological
scoring system was devised which showed a highly significant difference in liver
histology between standard diet and liquid-diet rats treated with 20 mg/kg/wk DMH.
The results strongly suggest an association between severity of liver damage from
DMH and the subsequent development of small-bowel tumours. The all-liquid diet
protected rats from liver damage and these rats developed significantly fewer small-
bowel tumours.
SINCE 1962, when naturally occurrinig
cycasin from the cycad plant was found to
be carcinogenic in laboratory rodents
(Laqueur & Spatz, 1968), an exponential
number of publications has appeared
describing various experiments using
cycasin or its metabolic analogues: 1,2-
dimethylhydrazine (DMH), azoxymethane
(AOM) and methylazoxymethanol (MAM).
We have reviewed 4 papers published
between 1967 and 1970; 14 between 1971
and 1973; 34 between 1974 and 1976; and
-50 which have appeared more recently.
These fall into 4 main groups: (1) early
studies of the gastrointestinal carcino-
genicity of these compounds; (2) histo-
pathology and tumour morphogenesis;
(3) aetiological experiments; and (4) more
specific carcinogenesis studies at the
cellular level.
In general, it would seem that almost
any alteration in the diet, or operative
procedure, can alter the incidence of
gastrointestinal tumours in rats treated
with these compounds. Different species of
rats have varying susceptibilities to gastro-
intestinal carcinogenesis with cycad an-
alogues, and thus possible mechanisms of
carcinogenesis cannot be deduced from the
aetiological studies reported to date.
Some observations have been made on
the morphological changes in the liver72W. M. CASTLEDEN AND K. B. SHILKIN
cells in animals treated with DMH (Ward
et al., 1973; Martin et al., 1973; Hawks et
al., 1974) but a correlation ofthe degree of
liver damage with the site of gastro-
intestinal cancers has received scant
attention.
Earlier papers evaluating the results of
experiments using cycasin or its analogues
(Laqueur & Spatz, 1968; Weisberger,
1971) suggested that a carcinogenic
metabolite might be delivered via the bile
to the gastrointestinal tract. More re-
cently this has been refuted by other wor-
kers (Hawks & Magee, 1974; Fiala, 1975;
1977) who have used 14C-labelled DMH,
and have recovered only small amounts of
the isotope from the rat bile. Hence there
is a need for clarification of the role of the
liver in the carcinogenesis model. In a pre-
liminary report (Castleden, 1977) it was
shown that at necropsy the livers of rats
treated with DMH at a dose of 20 mg/kg/
wk appeared "granular", whereas the
livers of rats treated with 10 mg/kg/wk
DMH appeared macroscopically normal.
In that report the 20 mg/kg/wk DM1H-
treated rats died early in the experiment
from chemical toxicity. Here we describe
these changes in more detail, and give the
results ofa further experiment designed to
investigate the relationship between
hepatocellular injury and gastrointestinal
tumour development, comparing the effect
ofthe all-liquid diet with the standard diet
in male Wistar rats treated with DMH.
MATERIALS AND METHODS
Male Wistar rats, bred at the Animal
Breeding Centre of the University ofWestern
Australia, 8-10 weeks old and wEeighing
-230 g, wrere used in these experiments.
They were wreighed and injected s.c. at the
same time each week with 2% (w/v) 1,2-
dimethylhydrazine dihydrochloride (Aldrich
Chemical Co. Inc.) in normal saline containing
1-5% (w/v) EDTA. pH 6-4, at dosages of
either 10 or 20 mg DMH base/kg body wt.
Dosages of 20 mg/kg/wNk DMH w-%ere adminis-
tered for 20 wreeks. Dosages of 10 mg/kg/wk
DMH were administered for 22 weeks. Con-
trol rats were injected uweekly with an
equivalent volume ofnormal saline containiing
1-5% (w/v) EDTA, pH 6-4. Injections were
given beneath the lax skin ofthe groin region,
the sides being alternated from week to week.
All surviving rats were killed 2 weeks after
their last injection.
Blood (8-10 ml) was obtained by heart
puncture after ether anaesthesia. Liver func-
tion tests (bilirubin, alkaline phosphatase,
aspartic serum transaminase (SGOT), serum
albumin and total protein levels) were
measured using a Vickers MC 300 Multi-
channel Auto Analyser.
Full necropsies were carried out on all
except 10 of the 246 animals. These 10 rats,
treated with 20 mg/kg/wk DHM, died un-
expectedly early in the experiment and were
either partly cannibalized or autolysed.
Subsequently, moribund animals were killed
wi-ith ether and necropsy undertaken immedi-
ately. All areas of nodularity in the gastro-
intestinal tract were measured and indicated
on specially designed charts, and appropriate
gut and liver tissue was fixed in 10% buffered
formol saline. All sections taken from paraffin
blocks were stained with haematoxylin and
eosin, and representative sections were
stained by PAS before and after diastase
digestion. Some formalin-fixed liver was
stained, after frozen section, with Oil-Red-O
to demonstrate lipid.
Standard sections ofliver from 77 rats were
examined by one of us (K.B.S.) without
knowledge of the dosage of DMH or diet
used. Central and peripheral zones of the
hepatic lobule were studied and separately
scored from 0 to 3 on arbitrary scales for the
degree of (1) liver-cell degeneration, (2)
hepatocytic necrosis and (3) inflammatory
infiltration. However, there were no statistic-
ally significant differences between changes
in the central and peripheral zones, and these
two scores were pooled. Total scores for each
group were calculated as a percentage of the
total possible score.
Two experiments were conducted. Rats in
the first experiment were fed 1 of 7 diets.
the details of wrhich have been previously
reported (Castleden, 1977). Essentially Diets
1 to 6 consisted ofMilne's standard laboratory
diet with or without the addition of various
bulking agents. There was no significant
difference in tumour incidence with any of
these solid diets, which have therefore been
grouped together (see Table 1) as "Solid
Diets". In the second experiment, rats were
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fed either Milne's standard laboratory diet
and treated with 20 mg/kg/wk DMH, or they
were fed the all-liquid diet and injected with
either DMH solute alone or with 20 mg/kg/
wk DMH. The standard diet was fed ad
libitum, whilst the all-liquid diet was adminis-
tered 12-hourly because of possible deteriora-
tion if kept for longer periods at room
temperature.
TABLE I.-Number of rats in each dietary
group
Control 10 mg/kg/wk 20 mg/kg/wk
(No DMH) DMH DMH
Solid diets'
Exp. 1
Exp. 2
Total
All-liquid
diet2
(VivonexR)
Exp. 1
Exp. 2
Total
30
30
60
60
5
5
10
93
20
113
8
8
Notes:
1 Milne's laboratory diet alone or separately sup-
plemented (see Castleden, 1977). Milne's laboratory
diet is a standardized, pelleted, rodent diet made
from a mixture of cereals, fish meal, milk powder,
sugar, tallow and yeast, yielding on analysis 21-2%
crude protein (3-3% nitrogen), 4.9% crude fat, 4-4%
crude fibre, 5-3% ash, 11-5% moisture and 52-7%
nitrogen-free extractives (carbohydrate), with stan-
dard concentrations of essential minerals, including
1-01% Ca, 0-16% Mg, 0-29% Na, 0-78% K, 38 parts/
106 Mn, 170 parts/106 Cu, 230 parts/106 Fe, 160
parts/106 Zn, 7% P04 (as P).
2 Vivonex® (Norwich Eaton) 160 g (2 sachets
dissolved in 900 ml water) which was administered
to rats in the liquid-diet group twice daily; these
rats received no pellets. This diet contains 1-22% N
as pure L-amino acids, 0-54% fat (safflower oil) and
85% carbohydrate with essential vitamins and
minerals, including 1-66% Ca, 0-72% Mg, 3-22% Na,
4-38% K, 58-4 parts/106 Mn, 40 5 parts/106 Cu,
207-5 parts/106 Fe, 8-37 parts/106 Zn, 1-66% P04
(as P).
RESULTS
Survival
Control group.-All 40 rats in this group
survived the whole 24 weeks ofthe experi-
ment without any clinical or histological
evidence ofabnormality.
lOmg/kg/wk group.-In this group, 62 of
the 68 rats treated with weekly injections
of 10 mg/kg/wk DMH survived until the
24th week of the experiment (after a total
dose of 220 mg/kg DMH). They were then
killed. Six solid-diet rats were killed
shortly before the end of the experiment
because of clinical evidence of tumour
development, as judged by anaemia or
bleeding from the rectum or ear. There
was no clinical or gross necropsy evidence
of chemical toxicity in any of the 10mg/
kg/wk rats.
20mg/kg/wk group.-The survival time
ofthe 20mg/kg/wk rats in the first experi-
ment has already been reported (Castle-
den, 1977). Similar results were obtained
in the second experiment, in which all 20
rats on the standard diet died early,
presumably from chemical toxicity, by
the 18th week of injections (Fig. 1). Once
again the rats on the all-liquid diet treated
with 20 mg/kg/wk DMH survived the full
term of the experiment, with the excep-
tion ofone rat which was killed in the 19th
week of the experiment because of rectal
bleeding. Necropsy revealed that the
bleeding was due to the intussusception of
a small-bowel tumour. The mean survival
of the 20 standard-diet rats in the second
experiment was 112± 19 days, compared
to 153+1P0 days for the 15 liquid-diet rats.
Table I shows the number of rats in each
group with further details of the composition
of the two dietary groups.
In the first experiment, the liquid-diet rats
lost weight for the first 8-10 days after transi-
tion from their previous standard diet.
Thereafter weekly weight was the same for
both dietary groups. In the second experi-
ment there was comparable weekly weight
gain in both the liquid-diet and standard-diet
animals. Both diets were therefore presumed
to be isocaloric.
Tumour analysis
A detailed tumour analysis of the first
group of experiments has already been
published (Castleden, 1977). Fig. 2 shows
the site of tumour development in the
animals receiving 10 mg/kg/wk DMH and
Fig. 3 shows the same for animals with
20 mg/kg/wk DMH. In the first dietary
experiment 60 solid-diet rats were treated
with 10 mg/kg/wk DMH and these
developed 29 small-bowel tumours and 85
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FIG. 1. Survival culrve for secon(ldietary experiment. 20 standard-diet rats (+) were all deadl by the
18th week of the experiment, when 15 liquid-diet rats (V) weire still alive. All rats received
20 mg/kg/wk DMH.
PROXIMAL SMALL
BOWEL (duodenum ) PROXIMAL SMALL
BOWEL duodenum
CAECUM
FIG. 2. Necropsy chart showing the sites of
tumour development in rats treated with
10 mg/kg/wk DMH in the first dietary
experiment.
TABLE II. First dietary experiment: total
number of tumours in all groups on solid
diet
Small bowel
Large bowel
10 mg/kg/wk DMH 20 mg/kg/wk DMH
(60 rats) (75 rats*)
29 84
85 60
x2=27-97, P= <0-001
* Rats dying before the 13th week of the experi-
ment were excluded: no tumours were observed in
any dietary group before this.
large-bowel tumours. Ofthe solid-diet rats,
75 survived 13 or more weeks ofinjections
with 20 mg/kg/wk DMH, and they
developed 84 small-bowel tumours and 60
UAtUUM
F1XIG(. 3. Necropsy chart showing the site of
tumour development in rats treate(d with
20 mg/kg/wk DMH in the first dietary
experiment.
large-bowel tumours. Table II summarizes
these results. The higher dose of DMH not
only caused early death from presumed
chemical toxicity but also caused a highly
significant increase in small-bowel
tumours (X2=27-97, P<0 001). Tumour
development in the second experiment
correlated very closely with the experience
with similar animals in the first group of
experiments. This is shown in Table III.
In both experiments the liquid-diet
animals were clinically protected from
chemical toxicity and developed signifi-
cantly fewer small-bowel tumours than
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TABLE III. Standard-diet and liquid-diet survival and tumour incidence in 20 mg/kg/wk
D)MH-treated rats in both experiments, showing close reproducibility of results
Ist Experiment
2nd(I Experiment
l'otals
Standlard diet
No. of iats AMean Snmall- Large-
-'-- -~ suirvival bowel bowel
(a) (b) (c) ((lays) tumours tumours
20 12 8 104 9 4
20 16 13 112 14 10
40 28 21 109 2:3 14
Liquid diet
No. of rats Mean Small- Laige-
c A_-- sturvival bowel bowel
(a) (b) (c) ((lays) tumours tumouios
10 10 8 155 1 11
15 15 12 153 4 15
25 25 20 154 5 26
(a) Treate(l.
(b) Surviving to 13 -weeks -when first tumour-bearing rat wvas idleiitifie(l.
(e) With ttumouirs at necropsy.
TABLE IV. Distribution ofgastrointestinal
tumours in tumour-bearing rats treated
with 20 my/ky/wk DJIH and fed eithelr
standard or all-liquid diet
Sinall-bowel
tumoums
Lar-ge-bo-wel
t u111o011rs
S;tandard (Iliet
(21 rats)
23
14
(meani total (lose-
310 mg/kg DM1IH)
x2
_ 4 76? < 46 0-001
STANDARD DIET
All-liqui(d dliet
(20 oats)
26
(meani total (lose-
400 mg/kg DAl H)
LIQUID DIET
A B C A B
FI(D. 4. Changes in liver-funcetion tests
showing percentage deviatioii from control
levels in rats on either standlard (liet or
liqoDi(d diet, treatecl with 2 doses of DMH.
0 bilirubin; A alkaline phosphatase;
n aspai-tic seruim transaminase (SGOT);
albtumin; 0 total protein. A contl-ol;
10 mg/kg/w,xk DMH; C 20 mg/kg/xs k
)AM Ff.
the standard-diet animals, which died
early (x2 14-76, P<0001 : see Table IV).
Blood tests
Blood was obtained from 29 standard-
diet and 36 liquid-diet rats. The results are
shown in Fig. 4, where the median per-
centage deviation from control values is
shown for 5 different liver function tests.
The greatest deviations were observed il
the standard-diet rats receiving 20 mg/kg/
wk DMH. Standard univariate and multi-
variate analyses were performed on the
complete blood data. The deviations
observed in the all-liquid diet rats re-
ceiving 20 mg/kg/wk DMH, and in both
dietary groups receiving 10 mg/kg/wk
DMH were significantly lower, indicating
much less liver damage.
Liver histology
The results of histological examination
and scoring are shown in Table V.
In general, because of the clear-cut
TABLE V. Pathology scorest of liver dam-
age in DMH-treated rats on two different
diets
Degen- Inflam-
Group (No.) eiation Necrosis mationi
1. Control (15) 13-3 0-0 0-0
2. Liquid cliet (25)
20 mg/kg/wk D1IH 68-6* 0-0 16.7*
3. Standard diet (37)
20 mg/kg/wk DAIH 75-6 47-2** 56-3**
t Percentage of the maximum possible score.
* Grouip 2 significantly lifferent from GrotDp 1
(P<0-001).
** Group 3 significaintly (liffereint, fr om Gr-oup 2
(P 0-001).
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FiG. 5.- Control-Liver from an animal which had not received DMH and which had been on an all-
liquid diet. The histological appearances of the liver are essentially normal, apart from some
minimal cytoplasmic vacuolation. H. & E. x 490.
FiG. 6.-20 mg/kg/wk DMH and all-liquid diet-Liver from an animal that was scored as 3 for
vacuolation and 0 for necrosis and inflammation. Note the severe degree ofvacuolation ofvirtually
all hepatocytes and the absence of necrosis or inflammatory infiltrate. H. & E. x 490.
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FIG. 7. 20tng/kg/uxk DMH enuld stendiifard diet Liver from an animal that was scoireci 2 for vacuolationi,
3 for necrosis andl 3 for inflammation. A number of vacuolated cells are apparent, but the presence
of necrosis is more obvious and there is a fairly intense inflammatory infiltrate. H. & E. x 490.
differences in the degree of liver-cell
vacuolation and/or inflammation, it was
immediately obvious which liver sections
had come from 20 mg/kg/wk DMH-
treated rats (Figs. 6 & 7) and which had
come from control rats (Fig. 5). These
differences were compared utsing Student's
t test: t38-9 32, P<0 001 for control rats
v's liquid-diet, 20 mg/kg/wk DMH-treated
rats; and t50 12-24, P<0-001 for control
rats vs standard diet 20 mg/kg/wk DMH-
treated rats. Furthermore, there was no
difficulty in determining which of the
20mg/kg/wk animals had been taking the
all-liquid diet (Fig. 6) and which had been
taking the standard diet (Fig. 7). There
were obvious differences in the amount of
cell necrosis and degree of inflammatory
cell infiltrate (t60-7 93, P<0 001), both
of which were greater in the latter.
A more detailed account of these histo-
logical changes is being underaken.
DISCUSSION
The first experiment showed that altera-
tion in the diet affected survival as well as
gastrointestinal tumour production when
Wistar rats were treated with 20 mg/kg/
wk DMH. An all-liquid elemental diet
(Vivonex) enabled rats to survive 20 weeks
of injections with 20 mg/kg/wk DMH,
which they failed to do on a standard
laboratory pelleted diet. The second ex-
periment confirmed these observations.
All the rats, on either diet, survived re-
peated injections of 10 mg/kg/wk DMH.
However, with this regime the pre-
dominant site of tumour development was
different from that of rats treated with
20 mg/kg/wk DMH, which were signifi-
cantly more likely to develop small-bowel
tumours. This pattern of tumour distribu-
tion has been proposed as likely by
Wiebecke et al. (1973) using DMH, and by
Ward et al. (1973) using two different
doses of AOM, but these workers had
based their predictions on very small
numbers of animals.
In both of our experiments there was a
change of tumour distribution, with a sig-
nificant reduction in the number of small-
bowel trumours, in 20mg/kg/wk rats on the
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all-liquid diet. The apparent increase in
large-bowel tumours in rats on the all-
liquid diet may simply reflect their longer
survival and their higher total dose of
DMH (see Table IV). Blood tests demon-
strated a high degree ofliver protection by
the all-liquid diet when rats were treated
with 20 mg/kg/wk DMH, and also con-
firmed that standard-diet rats treated
with 10 mg/kg/wk DMH suffered only
small alterations in liver function.
There was histological evidence of
severe hepatic toxicity in the standard-
diet rats treated with 20 mg/kg/wk DMH,
whereas feeding the all-liquid diet pro-
duced much less severe liver damage, both
biochemically and morphologically.
Ten mg/kg/wk DMH is a carcinogenic
dose for the strain of male Wistar rats we
have used, inducing predominantly large-
bowel tumours (Table II) and only slight
liver damage. Twenty mg/kg/wk DMH is
an excessive dose for these same animals
when used as a model for colonic-cancer
studies, since this dose increased the in-
duction of small bowel tumours. The shift
in tumour-site specificity with increased
(lose is an interesting phenomenon, and
may provide a basis for a better under-
standing of the mechanism of action of
this carcinogen. Equally important is the
fact that a different diet, the Vivonex all-
liquid diet, has the effect of negating the
toxicity, liver damage and alteration in
tumour site normally produced by the
higher dose ofDMH1. The reason for this is
not clear.
It is well established that many chemi-
cal carcinogens are metabolized to more
proximate carcinogens in the liver (Heidel-
berger, 1977) and there is evidence that
DMH is metabolized in the same manner
(Shank & Magee, 1967; Hawks & Magee,
1974). The evidence presented here indi-
cates that higher doses ofDMH cause liver
damage sufficient to impair normal hepatic
function. Thus the rat-liver metabolism of
DMH may be changed during the course of
an experiment in which DMH is adminis-
tered by weekly injections. Such changes
eouild affect both the quantitative and
qualitative distribution of metabolites,
causing the altered profile of tumour dis-
tribution which we have observed in these
experiments.
One possibility which we are further in-
vestigating is increasing biliary excretion
of DMH and/or one or more ofits carcino-
genic metabolites as the liver becomes in-
creasingly damaged. Isotope experiments
(Hawks & Magee, 1974; Fiala, 1975) have
shown that only small quantities (<1%)
of an injected dose of 14C-labelled DMH
appear in the bile of rats with biliary
fistulae. These experiments were of short
duration and appeared to involve rats
which had not previously been subjected
to weekly injections of DMH. To our
knowledge, no information is available on
the biliary excretion of DMH and its
metabolites in the later stages of tumour
induction by weekly DMH injections.
Furthermore, the importance of biliary
excretion, whatever proportion of an in-
jected dose this represents, remains to be
established. This is of particular interest
since, if any enterohepatic circulation of
DMH and/or its metabolites were demon-
strated, the results of many apparently
conflicting animal metabolic, dietary and
operative experiments could be explained.
The results of our experiments suggest
that the liquid Vivonex diet in some way
protects the rat liver from the toxic
effects of the higher DMH dose. The
mechanism of this protection may have
important implications for further in-
vestigation of colonic carcinogenesis, and
warrants further study.
There is increasing support for the con-
cept that carcinoma of the colon in
humans is probably caused, in part, by
one or more environmental carcinogens
(Vitale, 1975; Pratt et al., 1977; Hill et al.,
1978). Possible pathways by which food
products might be converted to DMH or
its metabolites in humans have even been
postulated (Fiala, 1977).
It is unwise to extrapolate from animal
experiments to humans. Nevertheless, if
chemical carcinogens are eventually
proved to be implicated in human colonic-
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cancer production, the enterohepatic cir-
culation of such carcinogens could explain
the differences in dietary (Burkitt, 1973;
Wynder, 1975) and metabolic (Hill, 1975)
epidemiology in humans.
APPENDIX
Confirmation of the protective effect of
Vivonex all-liquid diet in the rat DMH
model has recently been presented to the
British Society of Gastroenterology Sept-
ember 1978 meeting (Cruse et al., 1978).
These experiments could not have been carried out
without the support and assistance of the other
members of the Department of Surgery in the
University of Western Australia. Particular thanks
are due to Dr Peter Detchon, Mrs Sue Kelly and Mrs
Vicky Wakelam. We would also like to thank Mr B.
Murphy for statistical advice, Mr H. Upenicks for
help with the illustrations, Mr H. Whyte for tech-
nical help and Mrs Sheila Saville and Shirley Ann
Poulton for typing.
The Vivonex used in these experiments was
kindly supplied by Norwich-Eaton Laboratories of
New York via Fawns and McAllan Pty Ltd of
Melbourne.
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